# A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

Study · id `cardio:ct-nct02152280` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02152280](<https://clinicaltrials.gov/study/NCT02152280>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02152280

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

## Technical summary

Registry record NCT02152280. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 320 participants (planned count; ClinicalTrials.gov record NCT02152280, source copy `cardio:ctgov-nct02152280-2014-06-02`, retrieved 2026-10-26)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT02152280, source copy `cardio:ctgov-nct02152280-2014-06-02`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02152280, source copy `cardio:ctgov-nct02152280-2014-06-02`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02152280, source copy `cardio:ctgov-nct02152280-2014-06-02`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02152280-2014-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
- Condition: Stroke
- Intervention (Drug): Danhong Injection
- Intervention (Drug): Normal Saline
- Lead sponsor: Beijing Bozhiyin T&S Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Bozhiyin T&S Co., Ltd. (`cardio:org-beijing-bozhiyin-t-s-co-ltd`)

## Provenance

Content hash: bcebce811b7b4b6ee09a44a38b2d92f778d34545668a3c79f31d59c383271245
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
